microMend Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Employees
  • 13
Employees
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 16

microMend General Information

Description

Developer of wound closure product designed to offer a new alternative to sutures and staples for skin closure. The company's product has the added feature of tiny micro staples that assist it to achieve similar holding strength to sutures and close wounds, enabling medical practitioners to close surgical incisions, lacerations and skin tears.

Contact Information

Website
www.micromendskinclosure.com
Formerly Known As
Marco Pharmaceuticals
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Medical Supplies
Primary Office
  • 500 Yale Avenue North
  • Suite 100
  • Seattle, WA 98109
  • United States
+1 (877) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

microMend Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 01-Jan-2021 00.000 Completed Generating Revenue
5. Later Stage VC (Series A1) 02-Mar-2017 00000 00.000 00.00 Completed Generating Revenue
4. Angel (individual) 31-Dec-2015 00.000 Completed Generating Revenue
3. Early Stage VC (Series A) 23-Dec-2014 00.000 00.000 00.000 Completed Generating Revenue
2. Grant 01-Dec-2012 $1.75M $15K Completed Generating Revenue
1. Early Stage VC 01-Jan-2010 $15K $15K Completed Startup
To view microMend’s complete valuation and funding history, request access »

microMend Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A1 0,000,000 00.000000 00.0 00.0 00 00.0 0.000
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view microMend’s complete cap table history, request access »

microMend Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of wound closure product designed to offer a new alternative to sutures and staples for skin closure. The comp
Medical Supplies
Seattle, WA
13 As of 2021
00.000
0000000000 0 00.000

000000

amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqu
0000000 00000000
Palo Alto, CA
000000000 -

0000000

usmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exer
0000000 00000000
Paris, France
00 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

microMend Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sciton Corporation Palo Alto, CA 000000000 -
0000000 Venture Capital-Backed Paris, France 00 000.00 000000000 000.00
0000000 Venture Capital-Backed San Luis Obispo, CA 00 000.00 000000000 - 000.00
0000000 0000000 Formerly VC-backed Campbell, CA 00 000.00 000000&0 000.00
000000000 00000000 Venture Capital-Backed Woburn, MA 00 000.00 00000000000 000.00
You’re viewing 5 of 14 competitors. Get the full list »

microMend Executive Team (4)

Name Title Board Seat Contact Info
Ronald Berenson MD Co-Founder, President, Chief Executive Officer and Board Member
Eli Sonkin Chief Financial Officer
Deon Miller Chief Commercial Officer
Marco Rolandi Ph.D Co-Founder & CSO
To view microMend’s complete executive team members history, request access »

microMend Board Members (9)

Name Representing Role Since
Cameron Pollock Self Board Member 000 0000
Edward Truitt JD Self Chairman 000 0000
Henry Kim Self Board Member 000 0000
Jens Quistgaard Ph.D Self Board Member 000 0000
John Brzezenski Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

microMend Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

microMend Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Caygan Capital Hedge Fund Minority 000 0000 000000 0
Elevate Capital Venture Capital Minority 000 0000 000000 0
Keiretsu Capital Venture Capital Minority 000 0000 000000 0
Michigan Capital Network Venture Capital Minority 000 0000 000000 0
Thynk Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 16 investors. Get the full list »

Ready to get started?

Request a free trial